AKBA · Akebia Therapeutics, Inc. · Documents
$0.64
-0.04 (-5.37%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$177.65M
Shares
277.11M
Volume · Oct 20
4.14M
Avg daily vol (3M)
6.72M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| DEFA14A | — | 2023-03-27 | — | |
| DEFA14A | — | 2023-03-24 | — | |
| DEFR14A | — | 2023-03-17 | — | |
| 10-K | — | 2023-03-10 | 2022-12-31 | |
| 8-K | — | 2023-03-09 | — | |
| 8-K | — | 2023-03-02 | 2023-02-28 | |
| DEF 14A | — | 2023-03-01 | 2023-04-11 | |
| 8-K | — | 2023-02-21 | — | |
| PRE 14A | — | 2023-02-17 | 2023-04-11 | |
| 8-K | — | 2023-01-09 | — | |
| 8-K | — | 2022-12-28 | 2022-12-22 | |
| 8-K | — | 2022-12-15 | 2022-12-14 | |
| 8-K | — | 2022-11-10 | 2022-11-09 | |
| 8-K | — | 2022-11-08 | 2022-11-07 | |
| 10-Q | — | 2022-11-03 | 2022-09-30 | |
| 8-K | — | 2022-11-03 | — | |
| 8-K | — | 2022-08-04 | — | |
| 10-Q | — | 2022-08-04 | 2022-06-30 | |
| 8-K | — | 2022-07-18 | 2022-07-15 | |
| 8-K | — | 2022-06-30 | — | |
| 8-K | — | 2022-06-10 | 2022-06-06 | |
| 8-K | — | 2022-05-13 | 2022-05-12 | |
| 10-Q | — | 2022-05-09 | 2022-03-31 | |
| 8-K | — | 2022-05-09 | — | |
| DEF 14A | — | 2022-04-28 | 2022-06-08 | |
| DEFA14A | — | 2022-04-28 | — | |
| 8-K | — | 2022-04-07 | — | |
| 8-K | — | 2022-04-07 | 2022-04-01 | |
| 8-K | — | 2022-03-30 | — | |
| 8-K | — | 2022-03-01 | — | |
| 10-K | — | 2022-03-01 | 2021-12-31 | |
| 8-K | — | 2022-02-22 | 2022-02-18 | |
| 8-K | — | 2022-01-24 | 2022-01-19 | |
| 8-K/A | — | 2021-12-15 | 2021-11-01 | |
| 8-K | — | 2021-11-04 | — | |
| 10-Q | — | 2021-11-04 | 2021-09-30 | |
| 8-K | — | 2021-11-01 | — | |
| 8-K | — | 2021-09-28 | 2021-09-22 | |
| 8-K | — | 2021-09-09 | — | |
| 8-K | — | 2021-08-24 | — | |
| 10-Q | — | 2021-08-05 | 2021-06-30 | |
| 8-K | — | 2021-08-05 | — | |
| 8-K | — | 2021-06-03 | 2021-06-02 | |
| 8-K | — | 2021-06-01 | — | |
| 8-K | — | 2021-05-10 | — | |
| 10-Q | — | 2021-05-10 | 2021-03-31 | |
| DEFA14A | — | 2021-04-22 | — | |
| DEF 14A | — | 2021-04-22 | 2021-06-02 | |
| 8-K | — | 2021-03-30 | — | |
| S-3ASR | — | 2021-02-25 | — |
Showing 101–150 of 181 filings
Key facts
CIK
1517022
CUSIP
00972D105
13F (30d)
17 filings
17 filers
Visit website
Investor relations